PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)-
Human Volunteers
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Small moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Human Volunteers cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Topamax Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 1 | CC |
Same molecule, other indications
PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →